1,859
Views
9
CrossRef citations to date
0
Altmetric
Brief Report

Characterization of H3.3K36M as a tool to study H3K36 methylation in cancer cells

&
Pages 917-922 | Received 11 Aug 2017, Accepted 05 Sep 2017, Published online: 11 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yang Yu, Sihan Wang, Ziqin Wang, Renwei Gao & Joohyun Lee. (2023) Arabidopsis thaliana: a powerful model organism to explore histone modifications and their upstream regulations. Epigenetics 18:1.
Read now
Yongkun Wang, Baozhen Sun, Qiao Zhang, Hang Dong & Jingzhe Zhang. (2019) p300 Acetylates JHDM1A to inhibit osteosarcoma carcinogenesis. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 2891-2899.
Read now

Articles from other publishers (7)

Varun SahuChao Lu. (2022) Oncohistones: Hijacking the Histone Code. Annual Review of Cancer Biology 6:1, pages 293-312.
Crossref
Sanne M. Janssen & Matthew C. Lorincz. (2021) Interplay between chromatin marks in development and disease. Nature Reviews Genetics 23:3, pages 137-153.
Crossref
Elodie Villa, Umakant Sahu, Brendan P. O’Hara, Eunus S. Ali, Kathryn A. Helmin, John M. Asara, Peng Gao, Benjamin D. Singer & Issam Ben-Sahra. (2021) mTORC1 stimulates cell growth through SAM synthesis and m6A mRNA-dependent control of protein synthesis. Molecular Cell 81:10, pages 2076-2093.e9.
Crossref
Kartik N. RajagopalanXiao Chen, Daniel N. Weinberg, Haifen ChenJacek Majewski, C. David Allis & Chao Lu. (2021) Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation. Proceedings of the National Academy of Sciences 118:9.
Crossref
Dylan Husmann & Or Gozani. (2019) Histone lysine methyltransferases in biology and disease. Nature Structural & Molecular Biology 26:10, pages 880-889.
Crossref
Jie Li, Jeong Hyun Ahn & Gang Greg Wang. (2019) Understanding histone H3 lysine 36 methylation and its deregulation in disease. Cellular and Molecular Life Sciences 76:15, pages 2899-2916.
Crossref
Alvaro Aytes, Arianna Giacobbe, Antonina Mitrofanova, Katia Ruggero, Joanna Cyrta, Juan Arriaga, Luis Palomero, Sonia Farran-Matas, Mark A. Rubin, Michael M. Shen, Andrea Califano & Cory Abate-Shen. (2018) NSD2 is a conserved driver of metastatic prostate cancer progression. Nature Communications 9:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.